GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (FRA:0OT) » Definitions » Institutional Ownership

Ocular Therapeutix (FRA:0OT) Institutional Ownership : 18.98% (As of May. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ocular Therapeutix Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ocular Therapeutix's institutional ownership is 18.98%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ocular Therapeutix's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ocular Therapeutix's Float Percentage Of Total Shares Outstanding is 99.60%.


Ocular Therapeutix Institutional Ownership Historical Data

The historical data trend for Ocular Therapeutix's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix Institutional Ownership Chart

Ocular Therapeutix Historical Data

The historical data trend for Ocular Therapeutix can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 24.18 24.69 24.69 21.99 22.20 21.17 19.98 19.98 18.63 18.98

Ocular Therapeutix Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Ocular Therapeutix (FRA:0OT) Business Description

Traded in Other Exchanges
Address
24 Crosby Drive, Bedford, MA, USA, 01730
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix (FRA:0OT) Headlines

No Headlines